Viewing Study NCT01538095


Ignite Creation Date: 2025-12-24 @ 2:15 PM
Ignite Modification Date: 2026-02-06 @ 9:08 AM
Study NCT ID: NCT01538095
Status: COMPLETED
Last Update Posted: 2016-10-03
First Post: 2012-02-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module